Pharmaceutical Contract Manufacturing Market – Global Industry Analysis and Forecast (2023–2029)

Pharmaceutical Contract Manufacturing Market is expected to reach US$ 196.12 Bn. at a CAGR of 7% during the forecast period 2029.

Pharmaceutical Contract Manufacturing Market Definition:

The Pharmaceutical contract manufacturing is an organization that serves the pharmaceutical industry and offers clients with comprehensive services from drug development over drug manufacturing.Pharmaceutical Contract Manufacturing MarketTo know about the Research Methodology :- Request Free Sample Report The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Global Pharmaceutical Contract Manufacturing Market Dynamics:

The scope of the report includes a detailed study of global and regional markets for the market with the reasons given for variations in the growth of the industry in certain regions. Pharmaceutical major players are increasingly relying on contract manufacturing, packaging services, and research to fulfill many basic needs and competencies. The companies endeavor to save costs and product development time while simultaneously being productive and efficient. Many dynamics in the pharma arena are influencing companies’ development and manufacturing strategies. On the other hand, the introduction of serialization and changing trade policies between economies are major market challenges.

Ongoing Trends:

The report covers all the trends playing a major role in the growth of the market over the forecast period. A key trend in biotechnology contract manufacturing is merging in the pharmaceutical contract manufacturing like in 2022 Thermo Fisher Scientific completed the acquisition of Patheon, making the world’s most comprehensive and sophisticated end to end CDMO partner.

Global Pharmaceutical Contract Manufacturing Market Segmentation:

Based on service, pharmaceutical API manufacturing segment is expected to grow at the highest xx% CAGR during the forecast period. Pharmaceutical API manufacturing dominated in terms of revenue because of the growing demand for high potency active pharmaceutical ingredients (HPAPI). Similarly, the report covers the segments in the markets such as service and end-user.

Region-wise Analysis:

The report offers a brief analysis of the major regions in the market, namely, APAC, Europe, North America, South America, and the MEA. North America’s pharmaceutical contract manufacturing market was valued at US$ xx Mn. in 2022 and is expected to reach a value of US$ xx Mn. by 2029, with a CAGR of xx% during the forecast period. The presence of a strong CRO segment in the region and the growing popularity of CMOs in the U.S and Mexico will significantly fuel the market growth in North America over the forecast period.

Global Pharmaceutical Contract Manufacturing Market Competitive Landscape:

The competitive landscape section in the pharmaceutical contract manufacturing market offers a deep dive into the profiles of the leading players operating in the global market landscape. It offers captivating insights on the key developments, differential strategies, and other crucial aspects of the companies having a stronghold in the market. In Feb 2021, Catalent has signed a contract with Zumutor Biologics, Inc, to manufacture Zumutor’s, ZM008, for the treatment of solid tumors. Zumutor is a biologics company that develops new Immuno-oncotherapeutics to drive transformational developments in cancer treatment. The objective of the report is to present a comprehensive analysis of the Global Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Market dynamics, structure by analyzing the market segments and projects the Global Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Pharmaceutical Contract Manufacturing Market make the report investor’s guide.

Global Pharmaceutical Contract Manufacturing Market Scope: Inquire before buying

Global Pharmaceutical Contract Manufacturing Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 122.13 Bn.
Forecast Period 2023 to 2029 CAGR: 7% Market Size in 2029: US $ 196.12 Bn.
Segments Covered: by Service Pharmaceutical Manufacturing Services Biologics Manufacturing Services Drug Development Services
by End User Big Pharma Small & Mid-size Pharma Generic Pharmaceutical Companies Other End Users

Global Pharmaceutical Contract Manufacturing Market, by Region

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Key players

1. Thermo Fisher Scientific Inc. 2. Catalent, Inc. 3. Lonza Group Ltd 4. Recipharm AB 5. Vetter Pharma International GmbH 6. Famar Health Care Services 7. Abbvie Inc. 8. Aenova Group 9. Consort Medical Plc 10. Almac Group 11. Siegfried Holding AG 12. Evonik Industries AG 13. Boehringer Ingelheim International GmbH 14. Beijing Landscape 15. Bushu Pharmaceuticals 16. Porton Fine Chemicals 17. Pfizer 18. Tianjin Pharmaceuticals 19. Recipharm 20. Catalent Frequently Asked Questions: 1. Which region has the largest share in Global Pharmaceutical Contract Manufacturing Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Pharmaceutical Contract Manufacturing Market? Ans: The Global Market is growing at a CAGR of 7% during forecasting period 2023-2029. 3. What is scope of the Global Pharmaceutical Contract Manufacturing market report? Ans: Global Pharmaceutical Contract Manufacturing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Pharmaceutical Contract Manufacturing market? Ans: The important key players in the Global Market are – Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GmbH, Famar Health Care Services, Abbvie Inc., Aenova Group, Consort Medical Plc, Almac Group, Siegfried Holding AG, Evonik Industries AG, Boehringer Ingelheim International GmbH, Beijing Landscape, Bushu Pharmaceuticals, Porton Fine Chemicals, Pfizer, Tianjin Pharmaceuticals, Recipharm, and Catalent 5. What is the study period of this market? Ans: The Global Pharmaceutical Contract Manufacturing Market is studied from 2022 to 2029.
Global Pharmaceutical Contract Manufacturing Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Pharmaceutical Contract Manufacturing Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecast 6.1. Pharmaceutical Contract Manufacturing Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecast, by End User 7.1. Introduction and Definition 7.2. Key Findings 7.3. Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User 7.4. Pharmaceutical Contract Manufacturing Market Size (US$ Bn) Forecast, by End User 7.5. Pharmaceutical Contract Manufacturing Market Analysis, by End User 7.6. Pharmaceutical Contract Manufacturing Market Attractiveness Analysis, by End User 8. Global Pharmaceutical Contract Manufacturing Market Analysis and Forecast, by Service 8.1. Introduction and Definition 8.2. Key Findings 8.3. Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service 8.4. Pharmaceutical Contract Manufacturing Market Size (US$ Bn) Forecast, by Service 8.5. Pharmaceutical Contract Manufacturing Market Analysis, by Service 8.6. Pharmaceutical Contract Manufacturing Market Attractiveness Analysis, by Service 9. Global Pharmaceutical Contract Manufacturing Market Analysis, by Region 9.1. Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Region 9.2. Pharmaceutical Contract Manufacturing Market Size (US$ Bn) Forecast, by Region 9.3. Pharmaceutical Contract Manufacturing Market Attractiveness Analysis, by Region 10. North America Pharmaceutical Contract Manufacturing Market Analysis 10.1. Key Findings 10.2. North America Pharmaceutical Contract Manufacturing Market Overview 10.3. North America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User 10.4. North America Pharmaceutical Contract Manufacturing Market Forecast, by End User 10.4.1. Big Pharma 10.4.2. Small & Mid-size Pharma 10.4.3. Generic Pharmaceutical Companies 10.4.4. Other End Users 10.5. North America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service 10.6. North America Pharmaceutical Contract Manufacturing Market Forecast, by Service 10.6.1. Pharmaceutical Manufacturing Services 10.6.1.1. Pharmaceutical API Manufacturing 10.6.1.2. Pharmaceutical FDF Manufacturing 10.6.1.2.1. Parenteral/Injectable 10.6.1.2.2. Tablet 10.6.1.2.3. Capsule 10.6.1.2.4. Oral Liquid 10.6.1.2.5. Other Formulations 10.6.2. Biologics Manufacturing Services 10.6.2.1. Biologics API Manufacturing 10.6.2.2. Biologics FDF Manufacturing 10.6.3. Drug Development Services 10.7. North America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Country 10.8. North America Pharmaceutical Contract Manufacturing Market Forecast, by Country 10.8.1. The U.S. 10.8.2. Canada 10.9. North America Pharmaceutical Contract Manufacturing Market Analysis, by Country 10.10. U.S. Pharmaceutical Contract Manufacturing Market Forecast, by End User 10.10.1. Big Pharma 10.10.2. Small & Mid-size Pharma 10.10.3. Generic Pharmaceutical Companies 10.10.4. Other End Users 10.11. U.S. Pharmaceutical Contract Manufacturing Market Forecast, by Service 10.11.1. Pharmaceutical Manufacturing Services 10.11.1.1. Pharmaceutical API Manufacturing 10.11.1.2. Pharmaceutical FDF Manufacturing 10.11.1.2.1. Parenteral/Injectable 10.11.1.2.2. Tablet 10.11.1.2.3. Capsule 10.11.1.2.4. Oral Liquid 10.11.1.2.5. Other Formulations 10.11.2. Biologics Manufacturing Services 10.11.2.1. Biologics API Manufacturing 10.11.2.2. Biologics FDF Manufacturing 10.11.3. Drug Development Services 10.12. Canada Pharmaceutical Contract Manufacturing Market Forecast, by End User 10.12.1. Big Pharma 10.12.2. Small & Mid-size Pharma 10.12.3. Generic Pharmaceutical Companies 10.12.4. Other End Users 10.13. Canada Pharmaceutical Contract Manufacturing Market Forecast, by Service 10.13.1. Pharmaceutical Manufacturing Services 10.13.1.1. Pharmaceutical API Manufacturing 10.13.1.2. Pharmaceutical FDF Manufacturing 10.13.1.2.1. Parenteral/Injectable 10.13.1.2.2. Tablet 10.13.1.2.3. Capsule 10.13.1.2.4. Oral Liquid 10.13.1.2.5. Other Formulations 10.13.2. Biologics Manufacturing Services 10.13.2.1. Biologics API Manufacturing 10.13.2.2. Biologics FDF Manufacturing 10.13.3. Drug Development Services 10.14. North America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis 10.14.1. By End User 10.14.2. By Service 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Pharmaceutical Contract Manufacturing Market Analysis 11.1. Key Findings 11.2. Europe Pharmaceutical Contract Manufacturing Market Overview 11.3. Europe Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User 11.4. Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User 11.4.1. Big Pharma 11.4.2. Small & Mid-size Pharma 11.4.3. Generic Pharmaceutical Companies 11.4.4. Other End Users 11.5. Europe Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service 11.6. Europe Pharmaceutical Contract Manufacturing Market Forecast, by Service 11.6.1. Pharmaceutical Manufacturing Services 11.6.1.1. Pharmaceutical API Manufacturing 11.6.1.2. Pharmaceutical FDF Manufacturing 11.6.1.2.1. Parenteral/Injectable 11.6.1.2.2. Tablet 11.6.1.2.3. Capsule 11.6.1.2.4. Oral Liquid 11.6.1.2.5. Other Formulations 11.6.2. Biologics Manufacturing Services 11.6.2.1. Biologics API Manufacturing 11.6.2.2. Biologics FDF Manufacturing 11.6.3. Drug Development Services 11.7. Europe Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Country 11.8. Europe Pharmaceutical Contract Manufacturing Market Forecast, by Country 11.8.1. Germany 11.8.2. The U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Pharmaceutical Contract Manufacturing Market Analysis, by Country 11.10. Germany Pharmaceutical Contract Manufacturing Market Forecast, by End User 11.10.1. Big Pharma 11.10.2. Small & Mid-size Pharma 11.10.3. Generic Pharmaceutical Companies 11.10.4. Other End Users 11.11. Germany Pharmaceutical Contract Manufacturing Market Forecast, by Service 11.11.1. Pharmaceutical Manufacturing Services 11.11.1.1. Pharmaceutical API Manufacturing 11.11.1.2. Pharmaceutical FDF Manufacturing 11.11.1.2.1. Parenteral/Injectable 11.11.1.2.2. Tablet 11.11.1.2.3. Capsule 11.11.1.2.4. Oral Liquid 11.11.1.2.5. Other Formulations 11.11.2. Biologics Manufacturing Services 11.11.2.1. Biologics API Manufacturing 11.11.2.2. Biologics FDF Manufacturing 11.11.3. Drug Development Services 11.12. U.K. Pharmaceutical Contract Manufacturing Market Forecast, by End User 11.12.1. Big Pharma 11.12.2. Small & Mid-size Pharma 11.12.3. Generic Pharmaceutical Companies 11.12.4. Other End Users 11.13. U.K. Pharmaceutical Contract Manufacturing Market Forecast, by Service 11.13.1. Pharmaceutical Manufacturing Services 11.13.1.1. Pharmaceutical API Manufacturing 11.13.1.2. Pharmaceutical FDF Manufacturing 11.13.1.2.1. Parenteral/Injectable 11.13.1.2.2. Tablet 11.13.1.2.3. Capsule 11.13.1.2.4. Oral Liquid 11.13.1.2.5. Other Formulations 11.13.2. Biologics Manufacturing Services 11.13.2.1. Biologics API Manufacturing 11.13.2.2. Biologics FDF Manufacturing 11.13.3. Drug Development Services 11.14. France Pharmaceutical Contract Manufacturing Market Forecast, by End User 11.14.1. Big Pharma 11.14.2. Small & Mid-size Pharma 11.14.3. Generic Pharmaceutical Companies 11.14.4. Other End Users 11.15. France Pharmaceutical Contract Manufacturing Market Forecast, by Service 11.15.1. Pharmaceutical Manufacturing Services 11.15.1.1. Pharmaceutical API Manufacturing 11.15.1.2. Pharmaceutical FDF Manufacturing 11.15.1.2.1. Parenteral/Injectable 11.15.1.2.2. Tablet 11.15.1.2.3. Capsule 11.15.1.2.4. Oral Liquid 11.15.1.2.5. Other Formulations 11.15.2. Biologics Manufacturing Services 11.15.2.1. Biologics API Manufacturing 11.15.2.2. Biologics FDF Manufacturing 11.15.3. Drug Development Services 11.16. Italy Pharmaceutical Contract Manufacturing Market Forecast, by End User 11.16.1. Big Pharma 11.16.2. Small & Mid-size Pharma 11.16.3. Generic Pharmaceutical Companies 11.16.4. Other End Users 11.17. Italy Pharmaceutical Contract Manufacturing Market Forecast, by Service 11.17.1. Pharmaceutical Manufacturing Services 11.17.1.1. Pharmaceutical API Manufacturing 11.17.1.2. Pharmaceutical FDF Manufacturing 11.17.1.2.1. Parenteral/Injectable 11.17.1.2.2. Tablet 11.17.1.2.3. Capsule 11.17.1.2.4. Oral Liquid 11.17.1.2.5. Other Formulations 11.17.2. Biologics Manufacturing Services 11.17.2.1. Biologics API Manufacturing 11.17.2.2. Biologics FDF Manufacturing 11.17.3. Drug Development Services 11.18. Spain Pharmaceutical Contract Manufacturing Market Forecast, by End User 11.18.1. Big Pharma 11.18.2. Small & Mid-size Pharma 11.18.3. Generic Pharmaceutical Companies 11.18.4. Other End Users 11.19. Spain Pharmaceutical Contract Manufacturing Market Forecast, by Service 11.19.1. Pharmaceutical Manufacturing Services 11.19.1.1. Pharmaceutical API Manufacturing 11.19.1.2. Pharmaceutical FDF Manufacturing 11.19.1.2.1. Parenteral/Injectable 11.19.1.2.2. Tablet 11.19.1.2.3. Capsule 11.19.1.2.4. Oral Liquid 11.19.1.2.5. Other Formulations 11.19.2. Biologics Manufacturing Services 11.19.2.1. Biologics API Manufacturing 11.19.2.2. Biologics FDF Manufacturing 11.19.3. Drug Development Services 11.20. Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by End User 11.20.1. Big Pharma 11.20.2. Small & Mid-size Pharma 11.20.3. Generic Pharmaceutical Companies 11.20.4. Other End Users 11.21. Rest of Europe Pharmaceutical Contract Manufacturing Market Forecast, by Service 11.21.1. Pharmaceutical Manufacturing Services 11.21.1.1. Pharmaceutical API Manufacturing 11.21.1.2. Pharmaceutical FDF Manufacturing 11.21.1.2.1. Parenteral/Injectable 11.21.1.2.2. Tablet 11.21.1.2.3. Capsule 11.21.1.2.4. Oral Liquid 11.21.1.2.5. Other Formulations 11.21.2. Biologics Manufacturing Services 11.21.2.1. Biologics API Manufacturing 11.21.2.2. Biologics FDF Manufacturing 11.21.3. Drug Development Services 11.22. Europe Pharmaceutical Contract Manufacturing Market Attractiveness Analysis 11.22.1. By End User 11.22.2. By Service 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Developments 12. Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis 12.1. Key Findings 12.2. Asia Pacific Pharmaceutical Contract Manufacturing Market Overview 12.3. Asia Pacific Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User 12.4. Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, by End User 12.4.1. Big Pharma 12.4.2. Small & Mid-size Pharma 12.4.3. Generic Pharmaceutical Companies 12.4.4. Other End Users 12.5. Asia Pacific Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service 12.6. Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Service 12.6.1. Pharmaceutical Manufacturing Services 12.6.1.1. Pharmaceutical API Manufacturing 12.6.1.2. Pharmaceutical FDF Manufacturing 12.6.1.2.1. Parenteral/Injectable 12.6.1.2.2. Tablet 12.6.1.2.3. Capsule 12.6.1.2.4. Oral Liquid 12.6.1.2.5. Other Formulations 12.6.2. Biologics Manufacturing Services 12.6.2.1. Biologics API Manufacturing 12.6.2.2. Biologics FDF Manufacturing 12.6.3. Drug Development Services 12.7. Asia Pacific Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Country 12.8. Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Pharmaceutical Contract Manufacturing Market Analysis, by Country 12.10. China Pharmaceutical Contract Manufacturing Market Forecast, by End User 12.10.1. Big Pharma 12.10.2. Small & Mid-size Pharma 12.10.3. Generic Pharmaceutical Companies 12.10.4. Other End Users 12.11. China Pharmaceutical Contract Manufacturing Market Forecast, by Service 12.11.1. Pharmaceutical Manufacturing Services 12.11.1.1. Pharmaceutical API Manufacturing 12.11.1.2. Pharmaceutical FDF Manufacturing 12.11.1.2.1. Parenteral/Injectable 12.11.1.2.2. Tablet 12.11.1.2.3. Capsule 12.11.1.2.4. Oral Liquid 12.11.1.2.5. Other Formulations 12.11.2. Biologics Manufacturing Services 12.11.2.1. Biologics API Manufacturing 12.11.2.2. Biologics FDF Manufacturing 12.11.3. Drug Development Services 12.12. India Pharmaceutical Contract Manufacturing Market Forecast, by End User 12.12.1. Big Pharma 12.12.2. Small & Mid-size Pharma 12.12.3. Generic Pharmaceutical Companies 12.12.4. Other End Users 12.13. India Pharmaceutical Contract Manufacturing Market Forecast, by Service 12.13.1. Pharmaceutical Manufacturing Services 12.13.1.1. Pharmaceutical API Manufacturing 12.13.1.2. Pharmaceutical FDF Manufacturing 12.13.1.2.1. Parenteral/Injectable 12.13.1.2.2. Tablet 12.13.1.2.3. Capsule 12.13.1.2.4. Oral Liquid 12.13.1.2.5. Other Formulations 12.13.2. Biologics Manufacturing Services 12.13.2.1. Biologics API Manufacturing 12.13.2.2. Biologics FDF Manufacturing 12.13.3. Drug Development Services 12.14. Japan Pharmaceutical Contract Manufacturing Market Forecast, by End User 12.14.1. Big Pharma 12.14.2. Small & Mid-size Pharma 12.14.3. Generic Pharmaceutical Companies 12.14.4. Other End Users 12.15. Japan Pharmaceutical Contract Manufacturing Market Forecast, by Service 12.15.1. Pharmaceutical Manufacturing Services 12.15.1.1. Pharmaceutical API Manufacturing 12.15.1.2. Pharmaceutical FDF Manufacturing 12.15.1.2.1. Parenteral/Injectable 12.15.1.2.2. Tablet 12.15.1.2.3. Capsule 12.15.1.2.4. Oral Liquid 12.15.1.2.5. Other Formulations 12.15.2. Biologics Manufacturing Services 12.15.2.1. Biologics API Manufacturing 12.15.2.2. Biologics FDF Manufacturing 12.15.3. Drug Development Services 12.16. ASEAN Pharmaceutical Contract Manufacturing Market Forecast, by End User 12.16.1. Big Pharma 12.16.2. Small & Mid-size Pharma 12.16.3. Generic Pharmaceutical Companies 12.16.4. Other End Users 12.17. ASEAN Pharmaceutical Contract Manufacturing Market Forecast, by Service 12.17.1. Pharmaceutical Manufacturing Services 12.17.1.1. Pharmaceutical API Manufacturing 12.17.1.2. Pharmaceutical FDF Manufacturing 12.17.1.2.1. Parenteral/Injectable 12.17.1.2.2. Tablet 12.17.1.2.3. Capsule 12.17.1.2.4. Oral Liquid 12.17.1.2.5. Other Formulations 12.17.2. Biologics Manufacturing Services 12.17.2.1. Biologics API Manufacturing 12.17.2.2. Biologics FDF Manufacturing 12.17.3. Drug Development Services 12.18. Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, by End User 12.18.1. Big Pharma 12.18.2. Small & Mid-size Pharma 12.18.3. Generic Pharmaceutical Companies 12.18.4. Other End Users 12.19. Rest of Asia Pacific Pharmaceutical Contract Manufacturing Market Forecast, by Service 12.19.1. Pharmaceutical Manufacturing Services 12.19.1.1. Pharmaceutical API Manufacturing 12.19.1.2. Pharmaceutical FDF Manufacturing 12.19.1.2.1. Parenteral/Injectable 12.19.1.2.2. Tablet 12.19.1.2.3. Capsule 12.19.1.2.4. Oral Liquid 12.19.1.2.5. Other Formulations 12.19.2. Biologics Manufacturing Services 12.19.2.1. Biologics API Manufacturing 12.19.2.2. Biologics FDF Manufacturing 12.19.3. Drug Development Services 12.20. Asia Pacific Pharmaceutical Contract Manufacturing Market Attractiveness Analysis 12.20.1. By End User 12.20.2. By Service 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Developments 13. Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Pharmaceutical Contract Manufacturing Market Overview 13.3. Middle East & Africa Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User 13.4. Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast, by End User 13.4.1. Big Pharma 13.4.2. Small & Mid-size Pharma 13.4.3. Generic Pharmaceutical Companies 13.4.4. Other End Users 13.5. Middle East & Africa Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service 13.6. Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast, by Service 13.6.1. Pharmaceutical Manufacturing Services 13.6.1.1. Pharmaceutical API Manufacturing 13.6.1.2. Pharmaceutical FDF Manufacturing 13.6.1.2.1. Parenteral/Injectable 13.6.1.2.2. Tablet 13.6.1.2.3. Capsule 13.6.1.2.4. Oral Liquid 13.6.1.2.5. Other Formulations 13.6.2. Biologics Manufacturing Services 13.6.2.1. Biologics API Manufacturing 13.6.2.2. Biologics FDF Manufacturing 13.6.3. Drug Development Services 13.7. Middle East & Africa Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Country 13.8. Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Pharmaceutical Contract Manufacturing Market Analysis, by Country 13.10. GCC Pharmaceutical Contract Manufacturing Market Forecast, by End User 13.10.1. Big Pharma 13.10.2. Small & Mid-size Pharma 13.10.3. Generic Pharmaceutical Companies 13.10.4. Other End Users 13.11. GCC Pharmaceutical Contract Manufacturing Market Forecast, by Service 13.11.1. Pharmaceutical Manufacturing Services 13.11.1.1. Pharmaceutical API Manufacturing 13.11.1.2. Pharmaceutical FDF Manufacturing 13.11.1.2.1. Parenteral/Injectable 13.11.1.2.2. Tablet 13.11.1.2.3. Capsule 13.11.1.2.4. Oral Liquid 13.11.1.2.5. Other Formulations 13.11.2. Biologics Manufacturing Services 13.11.2.1. Biologics API Manufacturing 13.11.2.2. Biologics FDF Manufacturing 13.11.3. Drug Development Services 13.12. South Africa Pharmaceutical Contract Manufacturing Market Forecast, by End User 13.12.1. Big Pharma 13.12.2. Small & Mid-size Pharma 13.12.3. Generic Pharmaceutical Companies 13.12.4. Other End Users 13.13. South Africa Pharmaceutical Contract Manufacturing Market Forecast, by Service 13.13.1. Pharmaceutical Manufacturing Services 13.13.1.1. Pharmaceutical API Manufacturing 13.13.1.2. Pharmaceutical FDF Manufacturing 13.13.1.2.1. Parenteral/Injectable 13.13.1.2.2. Tablet 13.13.1.2.3. Capsule 13.13.1.2.4. Oral Liquid 13.13.1.2.5. Other Formulations 13.13.2. Biologics Manufacturing Services 13.13.2.1. Biologics API Manufacturing 13.13.2.2. Biologics FDF Manufacturing 13.13.3. Drug Development Services 13.14. Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast, by End User 13.14.1. Big Pharma 13.14.2. Small & Mid-size Pharma 13.14.3. Generic Pharmaceutical Companies 13.14.4. Other End Users 13.15. Rest of Middle East & Africa Pharmaceutical Contract Manufacturing Market Forecast, by Service 13.15.1. Pharmaceutical Manufacturing Services 13.15.1.1. Pharmaceutical API Manufacturing 13.15.1.2. Pharmaceutical FDF Manufacturing 13.15.1.2.1. Parenteral/Injectable 13.15.1.2.2. Tablet 13.15.1.2.3. Capsule 13.15.1.2.4. Oral Liquid 13.15.1.2.5. Other Formulations 13.15.2. Biologics Manufacturing Services 13.15.2.1. Biologics API Manufacturing 13.15.2.2. Biologics FDF Manufacturing 13.15.3. Drug Development Services 13.16. Middle East & Africa Pharmaceutical Contract Manufacturing Market Attractiveness Analysis 13.16.1. By End User 13.16.2. By Service 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Developments 14. South America Pharmaceutical Contract Manufacturing Market Analysis 14.1. Key Findings 14.2. South America Pharmaceutical Contract Manufacturing Market Overview 14.3. South America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by End User 14.4. South America Pharmaceutical Contract Manufacturing Market Forecast, by End User 14.4.1. Big Pharma 14.4.2. Small & Mid-size Pharma 14.4.3. Generic Pharmaceutical Companies 14.4.4. Other End Users 14.5. South America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Service 14.6. South America Pharmaceutical Contract Manufacturing Market Forecast, by Service 14.6.1. Pharmaceutical Manufacturing Services 14.6.1.1. Pharmaceutical API Manufacturing 14.6.1.2. Pharmaceutical FDF Manufacturing 14.6.1.2.1. Parenteral/Injectable 14.6.1.2.2. Tablet 14.6.1.2.3. Capsule 14.6.1.2.4. Oral Liquid 14.6.1.2.5. Other Formulations 14.6.2. Biologics Manufacturing Services 14.6.2.1. Biologics API Manufacturing 14.6.2.2. Biologics FDF Manufacturing 14.6.3. Drug Development Services 14.7. South America Pharmaceutical Contract Manufacturing Market Value Share Analysis, by Country 14.8. South America Pharmaceutical Contract Manufacturing Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Pharmaceutical Contract Manufacturing Market Analysis, by Country 14.10. Brazil Pharmaceutical Contract Manufacturing Market Forecast, by End User 14.10.1. Big Pharma 14.10.2. Small & Mid-size Pharma 14.10.3. Generic Pharmaceutical Companies 14.10.4. Other End Users 14.11. Brazil Pharmaceutical Contract Manufacturing Market Forecast, by Service 14.11.1. Pharmaceutical Manufacturing Services 14.11.1.1. Pharmaceutical API Manufacturing 14.11.1.2. Pharmaceutical FDF Manufacturing 14.11.1.2.1. Parenteral/Injectable 14.11.1.2.2. Tablet 14.11.1.2.3. Capsule 14.11.1.2.4. Oral Liquid 14.11.1.2.5. Other Formulations 14.11.2. Biologics Manufacturing Services 14.11.2.1. Biologics API Manufacturing 14.11.2.2. Biologics FDF Manufacturing 14.11.3. Drug Development Services 14.12. Mexico Pharmaceutical Contract Manufacturing Market Forecast, by End User 14.12.1. Big Pharma 14.12.2. Small & Mid-size Pharma 14.12.3. Generic Pharmaceutical Companies 14.12.4. Other End Users 14.13. Mexico Pharmaceutical Contract Manufacturing Market Forecast, by Service 14.13.1. Pharmaceutical Manufacturing Services 14.13.1.1. Pharmaceutical API Manufacturing 14.13.1.2. Pharmaceutical FDF Manufacturing 14.13.1.2.1. Parenteral/Injectable 14.13.1.2.2. Tablet 14.13.1.2.3. Capsule 14.13.1.2.4. Oral Liquid 14.13.1.2.5. Other Formulations 14.13.2. Biologics Manufacturing Services 14.13.2.1. Biologics API Manufacturing 14.13.2.2. Biologics FDF Manufacturing 14.13.3. Drug Development Services 14.14. Rest of South America Pharmaceutical Contract Manufacturing Market Forecast, by End User 14.14.1. Big Pharma 14.14.2. Small & Mid-size Pharma 14.14.3. Generic Pharmaceutical Companies 14.14.4. Other End Users 14.15. Rest of South America Pharmaceutical Contract Manufacturing Market Forecast, by Service 14.15.1. Pharmaceutical Manufacturing Services 14.15.1.1. Pharmaceutical API Manufacturing 14.15.1.2. Pharmaceutical FDF Manufacturing 14.15.1.2.1. Parenteral/Injectable 14.15.1.2.2. Tablet 14.15.1.2.3. Capsule 14.15.1.2.4. Oral Liquid 14.15.1.2.5. Other Formulations 14.15.2. Biologics Manufacturing Services 14.15.2.1. Biologics API Manufacturing 14.15.2.2. Biologics FDF Manufacturing 14.15.3. Drug Development Services 14.16. South America Pharmaceutical Contract Manufacturing Market Attractiveness Analysis 14.16.1. By End User 14.16.2. By Service 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Vehicles and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Vehicles 15.2.3.2. M&A Key Players, Forward Integration and Backward 15.2.3.3. Integration 15.3. Company Profiles: Key Players 15.3.1. Thermo Fisher Scientific Inc. 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Catalent, Inc. 15.3.3. Lonza Group Ltd 15.3.4. Recipharm AB 15.3.5. Vetter Pharma International GmbH 15.3.6. Famar Health Care Services 15.3.7. Abbvie Inc. 15.3.8. Aenova Group 15.3.9. Consort Medical Plc 15.3.10. Almac Group 15.3.11. Siegfried Holding AG 15.3.12. Evonik Industries AG 15.3.13. Boehringer Ingelheim International GmbH 15.3.14. Beijing Landscape 15.3.15. Bushu Pharmaceuticals 15.3.16. Porton Fine Chemicals 15.3.17. Pfizer 15.3.18. Tianjin Pharmaceuticals 15.3.19. Recipharm 15.3.20. Catalent 16. Primary Key Insights

About This Report

Report ID 65189
Category Healthcare
Published Date July 2023
Updated Date
  • INQUIRE BEFORE BUYING